Re: Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data

✍ Scribed by Laguna, M. Pilar

• Book ID: 127083525
• Publisher: Lippincott Williams and Wilkins
• Year: 2014
• Tongue: English
• Weight: 61 KB
• Volume: 192
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2014.07.053